دورية أكاديمية

RiboScreen TM Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of Elastin.

التفاصيل البيبلوغرافية
العنوان: RiboScreen TM Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of Elastin.
المؤلفون: Wimmer, Bjoern, Schernthaner, Jan, Edobor, Genevieve, Friedrich, Andreas, Poeltner, Katharina, Temaj, Gazmend, Wimmer, Marlies, Kronsteiner, Elli, Pichler, Mara, Gercke, Hanna, Huber, Ronald, Kaefer, Niklas, Rinnerthaler, Mark, Karl, Thomas, Krauß, Jan, Mohr, Thomas, Gerner, Christopher, Hintner, Helmut, Breitenbach, Michael, Bauer, Johann W.
المصدر: International Journal of Molecular Sciences; Aug2024, Vol. 25 Issue 15, p8430, 26p
مصطلحات موضوعية: CYTOSKELETAL proteins, SMALL molecules, DRUG discovery, TOPICAL drug administration, ELASTIN
مستخلص: Elastin, a key structural protein essential for the elasticity of the skin and elastogenic tissues, degrades with age. Replenishing elastin holds promise for anti-aging cosmetics and the supplementation of elastic activities of the cardiovascular system. We employed RiboScreenTM, a technology for identifying molecules that enhance the production of specific proteins, to target the production of tropoelastin. We make use of RiboScreenTM in two crucial steps: first, to pinpoint a target ribosomal protein (TRP), which acts as a switch to increase the production of the protein of interest (POI), and second, to identify small molecules that activate this ribosomal protein switch. Using RiboScreenTM, we identified ribosomal protein L40, henceforth eL40, as a TRP switch to boost tropoelastin production. Drug discovery identified a small-molecule hit that binds to eL40. In-cell treatment demonstrated activity of the eL40 ligand and delivered increased tropoelastin production levels in a dose-dependent manner. Thus, we demonstrate that RiboScreenTM can successfully identify a small-molecule hit capable of selectively enhancing tropoelastin production. This compound has the potential to be developed for topical or systemic applications to promote skin rejuvenation and to supplement elastic functionality within the cardiovascular system. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:16616596
DOI:10.3390/ijms25158430